Skip to main content

Advertisement

SpringerLink
Log in

High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

Valosin-containing protein (VCP) is one of the AAA-ATPase superfamily members. The correlation between elevated expression of VCP and progression, prognosis, and the metastatic potential has been identified in various tumor types. However, the clinical impact of VCP in breast carcinoma has not been investigated. In the current study, the expression of VCP in 421 breast tumors and adjacent normal breast tissues was examined to investigate the correlation between VCP expression and clinicopathological features in patients with breast carcinoma. We found that the expression of VCP correlated with the TNM stage, Ki67 labeling, and lymph node metastasis (LNM). The expression of VCP was increased significantly in the cytoplasm of cancer cells compared to normal mammary epithelial cells, which was associated with decreased overall survival rates of patients with breast carcinoma (P < 0.001). In conclusion, this study demonstrates significant correlation between the cytoplasmic expression of VCP and adverse prognosis in breast carcinoma, suggesting that VCP may serve as a prognostic biomarker in breast carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Cancer IAfRo. Latest world cancer statistics global cancer burden rises to 14.1 million new cases in 2012: marked increase in breast cancers must be addressed. World Health Organization 2013:1–3.

  2. Xu Y, Hu B, Qin L, Zhao L, Wang Q, Wang Q, et al. Src-1 and twist1 expression positively correlates with a poor prognosis in human breast cancer. Int J Biol Sci. 2014;10:396–403.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Meyer H, Bug M, Bremer S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol. 2012;14:117–23.

    Article  CAS  PubMed  Google Scholar 

  4. Min T, Bodas M, Mazur S, Vij N. Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysema. J Mol Med (Berl). 2011;89:577–93.

    Article  CAS  Google Scholar 

  5. Ishigaki S, Hishikawa N, Niwa J-I, Iemura S-I, Natsume T, Hori S, et al. Physical and functional interaction between dorfin and valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. J Biol Chem. 2004;279:51376–85.

    Article  CAS  PubMed  Google Scholar 

  6. Vij N. AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential. J Cell Mol Med. 2008;12:2511–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321:1801–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Kidogami S, Miyata H, et al. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin Cancer Res. 2004;10:5558–65.

    Article  CAS  PubMed  Google Scholar 

  9. Yamamoto S, Tomita Y, Hoshida Y, Sakon M, Kameyama M, Imaoka S, et al. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis. Clin Cancer Res. 2004;10:651–7.

    Article  CAS  PubMed  Google Scholar 

  10. Yi P, Higa A, Taouji S, Bexiga MG, Marza E, Arma D, et al. Sorafenib-mediated targeting of the AAA(+) ATPase p97/VCP leads to disruption of the secretory pathway, endoplasmic reticulum stress, and hepatocellular cancer cell death. Mol Cancer Ther. 2012;11:2610–20.

    Article  CAS  PubMed  Google Scholar 

  11. Tsujimoto Y, Tomita Y, Hoshida Y, Kono T, Oka T, Yamamoto S, et al. Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res. 2004;10:3007–12.

    Article  CAS  PubMed  Google Scholar 

  12. Dai RM, Chen E, Longo DL, Gorbea CM, Li CC. Involvement of valosin-containing protein, an atpase co-purified with ikappaBalpha and 26 s proteasome, in ubiquitin-proteasome-mediated degradation of ikappaBalpha. J Biol Chem. 1998;273:3562–73.

    Article  CAS  PubMed  Google Scholar 

  13. Dai RM, Li C-CH. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin–proteasome degradation. Nat Cell Biol. 2001;3:740–4.

    Article  CAS  PubMed  Google Scholar 

  14. Karin M, Yamamoto Y, Wang QM. The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov. 2004;3:17–26.

    Article  CAS  PubMed  Google Scholar 

  15. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 1996;274:782–4.

    Article  CAS  PubMed  Google Scholar 

  16. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer-rationale and promise. Cancer Cell. 2003;4:257–62.

    Article  CAS  PubMed  Google Scholar 

  17. Klein JB, Barati MT, Wu R, Gozal D, Sachleben Jr LR, Kausar H, et al. Akt-mediated valosin-containing protein 97 phosphorylation regulates its association with ubiquitinated proteins. J Biol Chem. 2005;280:31870–81.

    Article  CAS  PubMed  Google Scholar 

  18. Matkovic B, Juretic A, Separovic V, Novosel I, Separovic R, Gamulin M, et al. Immunohistochemical analysis of ER, PR, HER-2, CK 5/6, p63 and EGFR antigen expression in medullary breast cancer. Tumori. 2008;94:838–44.

    PubMed  Google Scholar 

  19. Hsu C-Y, Ho DM-T, Yang C-F, Lai C-R, Yu I-T, Chiang H. Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest®. Am J Clin Pathol. 2002;118:693–8.

    Article  CAS  PubMed  Google Scholar 

  20. Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101:736–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Simon R, Mirlacher M, Sauter G. Tissue microarrays; molecular diagnosis of cancer, Springer, 2004, pp 377–89.

  22. Fessart D, Marza E, Taouji S, Delom F, Chevet E. P97/CDC-48: proteostasis control in tumor cell biology. Cancer Lett. 2013;337:26–34.

    Article  CAS  PubMed  Google Scholar 

  23. Asai T, Tomita Y, Nakatsuka SI, Hoshida Y, Myoui A, Yoshikawa H, et al. VCP (p97) regulates NFkB signaling pathway, which is important for metastasis of osteosarcoma cell line. Cancer Sci. 2002;93:296–304.

    CAS  Google Scholar 

  24. Xu S, Peng G, Wang Y, Fang S, Karbowski M. The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover. Mol Biol Cell. 2011;22:291–300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Rumpf S, Lee SB, Jan LY, Jan YN. Neuronal remodeling and apoptosis require VCP-dependent degradation of the apoptosis inhibitor DIAP1. Development. 2011;138:1153–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, et al. NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A. 2004;101:10137–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Shostak K, Chariot A. NF-kappaB, stem cells and breast cancer: the links get stronger. Breast Cancer Res. 2011;13:214.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Li T, Lu H, Shen C, Lahiri S, Wason M, Mukherjee D, et al. Identification of epithelial stromal interaction 1 as a novel effector downstream of Krüppel-like factor 8 in breast cancer invasion and metastasis. Oncogene 2013.

  29. Vandermoere F, El Yazidi-Belkoura I, Slomianny C, Demont Y, Bidaux G, Adriaenssens E, et al. The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J Biol Chem. 2006;281:14307–13.

    Article  CAS  PubMed  Google Scholar 

  30. Bose S, Chandran S, Mirocha JM, Bose N. The Akt pathway in human breast cancer: a tissue-array-based analysis. Mod Pathol. 2006;19:238–45.

    Article  CAS  PubMed  Google Scholar 

  31. Meyer MF, Seuthe IM, Drebber U, Siefer O, Kreppel M, Klein MO, et al. Valosin-containing protein (VCP/p97)-expression correlates with prognosis of HPV-negative oropharyngeal squamous cell carcinoma (OSCC). PLoS One. 2014;9, e114170.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zhu WW, Kang L, Gao YP, Hei Y, Dong J, Liu Y, et al. Expression level of valosin containing protein is associated with prognosis of primary orbital MALT lymphoma. Asian Pac J Cancer Prev. 2013;14:6439–43.

    Article  PubMed  Google Scholar 

  33. Liu Y, Hei Y, Shu Q, Dong J, Gao Y, Fu H, et al. VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma. PLoS One. 2012;7, e35800.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Valle CW, Min T, Bodas M, Mazur S, Begum S, Tang D, et al. Critical role of VCP/p97 in the pathogenesis and progression of non-small cell lung carcinoma. PLoS One. 2011;6, e29073.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by funding from the Heilongjiang Province Applied Technology Research and Development Project (No. GA13C201), the National Key Technology Support Program (No. 2013BAI09B00), and the National Natural Science Foundation of China (No. 81172498/H1622).

Conflict of interest

None

Author information

Authors and Affiliations

  1. Department of Breast Surgery, Harbin Medical University Cancer Hospital, Haping Road No.150, Nangang District, Harbin, 150081, Heilongjiang Province, China

    Yan Cui, Ming Niu, Xianyu Zhang, Zhenbin Zhong, Ji Wang & Da Pang

Authors
  1. Yan Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ming Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xianyu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhenbin Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ji Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Da Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Da Pang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cui, Y., Niu, M., Zhang, X. et al. High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma. Tumor Biol. 36, 9919–9927 (2015). https://doi.org/10.1007/s13277-015-3748-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3748-9

Keywords

Search

Navigation